Welcome to the official website of BioCoreUSA Corp!
  • Cores:
    72
    CASES:
    72
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    9
    Tissue Array Type:
    FFPE
    Species:
    Human
MBC721
$255.00
Add To Collect

Description: Multiple organ tumor tissue array, including pathology grade, TNM, clinical stage and IHC markers () results, 72 cases/72 cores

Details: Multiple organ tumor tissue microarray, containing 72 cases of multiple organ tumor, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Malignant(*)
  • Malignant(I)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • Malignant(III)
  • Malignant(IV)
  • _ma
TISSUE ARRAYS
MBC721
1
2
3
4
5
6
7
8
9
A
Bra
Bra
Hea
Ton
Sal
Sal
Lun
Lun
Lun
B
Lun
Bon
Bon
Eso
Eso
Sto
Sto
Sma
Sma
C
Sma
Col
Col
Col
Liv
Liv
Gal
Gal
Pan
D
Pan
App
App
Kid
Kid
Bla
Bla
Thy
Thy
E
Adr
Adr
Thy
Thy
Lym
Lym
Lym
Lym
Lym
F
Spl
Spl
Bre
Bre
Ova
Ova
Ute
Ute
Ute
G
Cer
Cer
Pro
Pro
Tes
Tes
Mes
Mes
Mus
H
Mus
Mus
Mus
Per
Per
Sof
Sof
Ski
Ski
_ma
MBC721
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size
A1
1 51 F Brain Oligodendroglioma * * * Malignant *
A2
2 42 F Brain Ependymoma * * * Malignant *
A3
3 41 M Head and neck Adenocarcinoma * T2N0M0 II Malignant 9*4*4
A4
4 53 M Tongue Squamous cell carcinoma * T3N0M0 III Malignant 5.5
A5
5 24 F Salivary gland Pleomorphic adenoma * * * Malignant *
A6
6 49 M Salivary gland Warthin's tumor with necrosis * * * Malignant *
A7
7 59 M Lung Adenocarcinoma * T2N0M0 IB Malignant 5*2.5*2
A8
8 56 M Lung Squamous cell carcinoma * T3N2M0 IIIB Malignant 7*6*5
A9
9 42 F Lung Small cell carcinoma * T4N1M0 IIIA Malignant *
B1
10 49 M Lung Atypical carcinoid * T4N2M0 IIIB Malignant *
B2
11 31 M Bone or extramedullary Multiple myeloma or plasmacytoma * * * Malignant 4.5
B3
12 19 M Bone Osteosarcoma * T2N0M0 G3 IIB Malignant *
B4
13 67 M Esophagus Adenocarcinoma * * * Malignant *
B5
14 65 F Esophagus Squamous cell carcinoma * * * Malignant 4*2.5*1.5
B6
15 48 M Stomach Adenocarcinoma * T3N2M0 III Malignant 5.5*5.0*0.5
B7
16 60 F Stomach Gastrointestinal stromal tumor (GIST) * * * Malignant *
B8
17 56 F Small intestine Adenocarcinoma * T3N2M0 IIIB Malignant 8
B9
18 38 M Small intestine Gastrointestinal stromal tumor (GIST) * * * Malignant 10*7*5
C1
19 54 F Small intestine Neuroendocrine carcinoma * T3N2M0 IIIB Malignant 7
C2
20 52 M Colon Adenocarcinoma * T3N2M0 IIIB Malignant 3*2*0.5
C3
21 73 F Colon Squamous cell carcinoma * T3N2aM0 IIIB Malignant 3*3*0.5cm
C4
22 46 M Colon Neuroendocrine carcinoma * T3N1M0 IIIB Malignant 7
C5
23 62 M Liver Cholangiocarcinoma * T2aN0M0 II Malignant 6
C6
24 58 M Liver Hepatocellular carcinoma * T2N0M0 II Malignant 7*7*6
C7
25 59 M Gallbladder Adenocarcinoma (grade:2--3) * T2N1M0 IIIB Malignant *
C8
26 56 F Gallbladder Adenocarcinoma (grade:3) * T3N1M0 IIIB Malignant *
C9
27 58 M Pancreas Islet cell tumor * * * Malignant *
D1
28 39 F Pancreas Ductal adenocarcinoma * T3N0M0 IIA Malignant 4*3*1
D2
29 46 F Appendix Carcinoid * T2N0M1 IV Malignant *
D3
30 59 M Appendix Adenocarcinoma * T2N1M0 IIIA Malignant *
D4
31 54 F Kidney Papillary renal adenoma * * * Malignant *
D5
32 71 F Kidney Renal cell carcinoma * T2N0M0 II Malignant 4
D6
33 58 M Bladder Squamous cell carcinoma * T3N0M0 III Malignant 3*3*2
D7
34 65 F Bladder Urothelial cell carcinoma * T3N0M0 III Malignant 4.5*4.0*2
D8
35 45 M Thyroid Follicular thyroid cancer * T2N0M0 I Malignant *
D9
36 51 F Thyroid Papillary thyroid cancer * T3N1M0 I Malignant 3.3*2.8*2.2
E1
37 17 F Adrenal gland Adenoma * * * Malignant 18*10*6.5
E2
38 50 M Adrenal gland Pheochromocytoma * * * Malignant 6*5*5
E3
39 35 M Thymus Type B3 thymoma * * * Malignant *
E4
40 48 M Thymus Thymic carcinoma * * * Malignant 8*6*6
E5
41 40 F Lymph nodes Islet cell tumor * * * Malignant 7*4*2.5
E6
42 17 M Lymph nodes Hodgkin's Lymphoma * * * Malignant *
E7
43 44 M Lymph nodes Mantle cell lymphoma * * * Malignant 4*6
E8
44 59 M Lymph nodes Follicular lymphoma * * * Malignant *
E9
45 30 M Lymph nodes T cell lymphoma * * * Malignant *
F1
46 60 M Spleen Diffuse large B cell lymphoma * * * Malignant *
F2
47 35 M Spleen Angiosarcoma * * * Malignant *
F3
48 72 F Breast Invasive ductal carcinoma * * * Malignant *
F4
49 41 F Breast Invasive lobular carcinoma * * * Malignant *
F5
50 84 F Ovary Granular cell tumor * T1aN0M0 IA Malignant 10*6*0.8
F6
51 45 F Ovary Serous carcinoma * T1aN0M0 IA Malignant *
F7
52 63 F Uterus Clear cell carcinoma with necrosis * T3bN1M0 IIIB Malignant 6*5*3
F8
53 53 F Uterus Endometrioid adenocarcinoma * T1bN0M0 IB Malignant 5.0*4.5*1.0
F9
54 48 F Uterus Uterine leiomyosarcoma * T2N1M0 IIIB Malignant 9*9*7
G1
55 41 F Cervix Adenocarcinoma * T1aN0M0 IA Malignant 5*4*3
G2
56 76 F Cervix Squamous cell carcinoma * T2N0M0 II Malignant 4*3*2.5
G3
57 73 M Prostate Adenocarcinoma (Gleason grade:4, Gleason score:4+4) * T2aN0M0 I Malignant 4*3.5*3
G4
58 69 M Prostate Adenocarcinoma (Gleason grade:1, Gleason score:2+1) * T3N0M0 III Malignant 4*3*2
G5
59 21 M Testis Embryonal carcinoma * T1N0M0 I Malignant *
G6
60 50 M Testis Seminoma * T1N0M0 I Malignant 4
G7
61 38 F Mesothelium Mesothelioma * * * Malignant 14*10*2
G8
62 F 34 Mesothelium Pleural solitary fibrous tumor * * * Malignant *
G9
63 20 F Muscle Alveolar rhabdomyosarcoma * T2N0M0 G4 IIIB Malignant 8*5*5
H1
64 55 M Muscle Myxoma * * * Malignant *
H2
65 40 F Muscle Myxoliposarcoma * T2aN0M0 G2 IIB Malignant 5
H3
66 43 F Muscle Myxofibrosarcoma * T1bN0M0 IIA Malignant 5
H4
67 55 F Peripheral nerve Neurofibrosarcoma * * * Malignant *
H5
68 61 F Peripheral nerve Schwannoma * * * Malignant *
H6
69 76 M Soft Tissue Angiosarcoma * * * Malignant *
H7
70 42 M Soft Tissue Liposarcoma * T1bN0M0 IIA Malignant 4
H8
71 55 M Skin Basal cell carcinoma * T2N0M0 II Malignant *
H9
72 68 M Skin Invasive melanoma * * * Malignant *
_marker_
Find overlapping cases with this tissue array:
  • MBC721
    File Format: .xlsx
    Release Date: 2025-01-17 16:02:44
    Download
1.657998s